Form 4: Surrozen Director Acquires Stock Options

Mary Haak-Frendscho, a director at Surrozen, Inc., acquired 5,550 stock options on May 13, 2026.

Summary

• Mary Haak-Frendscho, a director of Surrozen, Inc., was granted 5,550 stock options on May 13, 2026.
• These options have an exercise price of $30.14 and are exercisable starting May 13, 2027, with an expiration date of May 12, 2036.
• The options vest and become exercisable on the anniversary of the grant date, contingent upon continuous service as a director.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a standard insider equity grant that aligns director incentives with company performance, but does not provide new financial or strategic information.

Positives

• Director Mary Haak-Frendscho has been granted stock options, indicating continued commitment and potential alignment with shareholder interests.
• The grant of 5,550 stock options suggests confidence in the company's future prospects by a key insider.

Risks

• The vesting of options is contingent on continuous service as a director, meaning any departure from the board would impact exercisability.
• The exercise price of $30.14 implies that the stock price needs to appreciate significantly for these options to be profitable.

Future Outlook

The grant of stock options with a future vesting and exercise schedule suggests management's expectation of future stock price appreciation.

Industry Context

StockSavvy.ai notes that the granting of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, aligning executive incentives with long-term company performance and shareholder value.

Stakeholder Impact

• Shareholders: The alignment of director incentives through stock options may positively influence long-term shareholder value.
• Employees: Standard practice of equity grants to directors can be seen as a positive signal for overall company strategy and potential future growth.
• Management: Reinforces the standard compensation and incentive structures for key personnel.

Next Steps

• Director Haak-Frendscho will continue to serve Surrozen, Inc. to meet vesting requirements.
• The stock options will become exercisable on May 13, 2027, subject to continuous service.

Key Dates

Keywords

Surrozen, SRZN, Form 4, Stock Options, Director, Insider Trading, SEC Filing, Equity Award